AstraZeneca
A Scientist in Rare Cancer Discovery at AstraZeneca focuses on advancing drug discovery for rare cancers, particularly neuro-oncology, through experimental research and collaboration with cross-functional teams.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
16% below the average for this role
Scientist, Discovery Oncology
MSD
Associate Principal Scientist, Discovery Oncology
MSD
Senior Scientist I, Cell and Molecular Biologist Oncology Discovery
AbbVie
Senior Principal Scientist/Principal Scientist, Immune Engagers
Novartis
Senior Scientist (Discovery Biology)
Cancer Research UK
Senior Scientist
City of Duncan, Oklahoma